(XIU) iShares S&P/TSX 60 - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA46428D1087 • Canadian Equity

XIU: Financial, Healthcare, Energy, Consumer, Staples

The iShares S&P/TSX 60 Index ETF (XIU) is a Canadian exchange-traded fund designed to replicate the performance of the S&P/TSX 60 Index. This index comprises the 60 largest publicly traded companies on the Toronto Stock Exchange, representing a broad spectrum of sectors such as financial services, healthcare, energy, utilities, oil and gas, and consumer staples. The fund is managed by BlackRock and aims to deliver long-term capital growth by investing in blue-chip companies, which are typically characterized by their stability and dividend-paying history. As one of the most widely traded ETFs in Canada, XIU offers exposure to key sectors of the Canadian economy, making it a popular choice for investors seeking diversified domestic market exposure.

With an average daily trading volume of 5.27 million shares, XIU is highly liquid, ensuring efficient trade execution. The funds assets under management (AUM) total CAD 16.33 billion, reflecting its status as a major player in the Canadian ETF market. Its underlying portfolio includes some of Canadas most prominent corporations, providing a diversified investment across various industries. The ETFs structure allows it to closely track the S&P/TSX 60 Index, offering investors a cost-effective way to gain exposure to the Canadian equity market. Additionally, XIU is known for its regular dividend distributions, appealing to income-focused investors.

3-Month Forecast: Based on the provided and , the iShares S&P/TSX 60 Index ETF (XIU) is expected to remain stable with a potential upside. The SMA 50 (37.49) is above the SMA 200 (36.48), indicating a bullish medium-term trend, while the SMA 20 (36.74) is slightly below the last price (37.02), suggesting short-term consolidation. The ATR (0.78) indicates moderate volatility, with price fluctuations likely contained within a narrow range. Fundamentally, the large AUM (16.33B CAD) underscores the funds liquidity and investor confidence. Over the next three months, XIU is forecasted to trade sideways with a potential breakout above 38.00 if broader market conditions improve.

Additional Sources for XIU ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

XIU ETF Overview

Market Cap in USD 11,778m
Category Canadian Equity
IPO / Inception 1999-09-28

XIU ETF Ratings

Growth Rating 82.6
Fundamental -
Dividend Rating 68.3
Rel. Strength 6.34
Analysts -
Fair Price Momentum 38.96 CAD
Fair Price DCF -

XIU Dividends

Dividend Yield 12m 3.02%
Yield on Cost 5y 5.80%
Annual Growth 5y 6.75%
Payout Consistency 96.8%

XIU Growth Ratios

Growth Correlation 3m -78.1%
Growth Correlation 12m 83.9%
Growth Correlation 5y 89.4%
CAGR 5y 14.39%
CAGR/Max DD 5y 0.88
Sharpe Ratio 12m 1.08
Alpha 9.49
Beta 0.550
Volatility 23.52%
Current Volume 1550.9k
Average Volume 20d 5380.8k
What is the price of XIU stocks?
As of April 25, 2025, the stock is trading at CAD 37.62 with a total of 1,550,861 shares traded.
Over the past week, the price has changed by +2.45%, over one month by -2.03%, over three months by -2.09% and over the past year by +16.66%.
Is iShares S&P/TSX 60 a good stock to buy?
Yes. Based on ValueRay Analyses, iShares S&P/TSX 60 (TO:XIU) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.59 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XIU as of April 2025 is 38.96. This means that XIU is currently overvalued and has a potential downside of 3.56%.
Is XIU a buy, sell or hold?
iShares S&P/TSX 60 has no consensus analysts rating.
What are the forecast for XIU stock price target?
According to ValueRays Forecast Model, XIU iShares S&P/TSX 60 will be worth about 42.9 in April 2026. The stock is currently trading at 37.62. This means that the stock has a potential upside of +14.09%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 42.9 14.1%